3 unknown, 1 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Unknown 2 |
Follow TQ-B3101: new trials by email Literature Review of TQ-B3101 trials Research Report on TQ-B3101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects TQ-B3101 - Pharmacokinetic Study | Phase 1 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 16 | 2021-05-20 | 2022-01-21 |
| A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor TQ-B3101 - Advanced Malignant Tumor | Phase 2 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 200 | 2020-08-05 | 2020-08-18 |
| Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) TQ-B3101 - ROS1-positive Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 111 | 2019-07-24 | 2019-08-15 |
| A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics TQ-B3101 - Advanced Cancer | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 20 | 2017-07-05 | 2017-09-18 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (4)
China (4)